Search Results

There are 40495 results for: content related to: Depressive symptoms in Parkinson’s disease

  1. Long-term treatment with pramipexole in restless legs syndrome

    European Journal of Neurology

    Volume 13, Issue 12, December 2006, Pages: 1306–1311, J. Montplaisir, M. L. Fantini, A. Desautels, M. Michaud, D. Petit and D. Filipini

    Article first published online : 13 NOV 2006, DOI: 10.1111/j.1468-1331.2006.01459.x

  2. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release

    European Journal of Neurology

    Volume 18, Issue s1, March 2011, Pages: 3–10, O. Rascol

    Article first published online : 24 JAN 2011, DOI: 10.1111/j.1468-1331.2010.03326.x

  3. A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide

    European Journal of Neurology

    Volume 12, Issue 1, January 2005, Pages: 1–8, P. Navan, L. J. Findley, M. B. Undy, R. K. B. Pearce and P. G. Bain

    Article first published online : 21 DEC 2004, DOI: 10.1111/j.1468-1331.2004.01019.x

  4. Pramipexole in the treatment of restless legs syndrome: a follow-up study

    European Journal of Neurology

    Volume 7, Issue s1, May 2000, Pages: 27–31, J. Montplaisir, R. Denesle and D. Petit

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1468-1331.2000.0070s1027.x

  5. Dopamine agonists in the treatment of non-motor symptoms of Parkinson’s disease: depression

    European Journal of Neurology

    Volume 15, Issue s2, September 2008, Pages: 9–14, M. R. Lemke

    Article first published online : 12 AUG 2008, DOI: 10.1111/j.1468-1331.2008.02213.x

  6. Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson’s disease

    European Journal of Neurology

    Volume 20, Issue 1, January 2013, Pages: 50–56, A. H. V. Schapira, P. Barone, R. A. Hauser, Y. Mizuno, O. Rascol, M. Busse, C. Debieuvre, M. Fraessdorf, W. Poewe and for the Pramipexole ER Studies Group

    Article first published online : 27 APR 2012, DOI: 10.1111/j.1468-1331.2012.03712.x

  7. Do dopamine agonists or levodopa modify Parkinson's disease progression?

    European Journal of Neurology

    Volume 9, Issue s3, November 2002, Pages: 15–22, K. Marek, D. Jennings and J. Seibyl

    Article first published online : 11 DEC 2002, DOI: 10.1046/j.1468-1331.9.s3.2.x

  8. The first case of a ‘jumping stump’ syndrome in a lower limb amputee responding to pramipexole

    European Journal of Neurology

    Volume 18, Issue 4, April 2011, Pages: e45–e46, Stefan Seidel, Jasmin Kechvar-Parast, Thomas Sycha and Josef Zeitlhofer

    Article first published online : 15 DEC 2010, DOI: 10.1111/j.1468-1331.2010.03288.x

  9. Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease

    European Journal of Neurology

    Volume 18, Issue 11, November 2011, Pages: 1299–1303, Y. Baba, M.-A. Higuchi, K. Fukuyama, H. Abe, Y. Uehara, T. Inoue and T. Yamada

    Article first published online : 24 MAR 2011, DOI: 10.1111/j.1468-1331.2011.03391.x

  10. You have free access to this content
    Comparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 64, Issue 5, November 2007, Pages: 591–602, Ebony R. Samuels, Ruihua H. Hou, Robert W. Langley, Elemer Szabadi and Christopher M. Bradshaw

    Article first published online : 19 JUN 2007, DOI: 10.1111/j.1365-2125.2007.02938.x

  11. Pramipexole for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke, Julie Speller and J A Clarke

    Published Online : 24 APR 2000, DOI: 10.1002/14651858.CD002261

  12. Actometry in measuring the symptom severity of restless legs syndrome

    European Journal of Neurology

    Volume 12, Issue 5, May 2005, Pages: 385–387, K. Tuisku, M. M. Holi, K. Wahlbeck, A. J. Ahlgren and H. Lauerma

    Article first published online : 24 MAR 2005, DOI: 10.1111/j.1468-1331.2004.00960.x

  13. Clinical risk–benefit assessment of dopamine agonists

    European Journal of Neurology

    Volume 15, Issue s2, September 2008, Pages: 15–23, J. C. Möller, K. M. Eggert, M. Unger, P. Odin, K. R. Chaudhuri and W. H. Oertel

    Article first published online : 12 AUG 2008, DOI: 10.1111/j.1468-1331.2008.02214.x

  14. You have full text access to this OnlineOpen article
    Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease

    European Journal of Neurology

    Volume 21, Issue 5, May 2014, Pages: 736–743, R. A. Hauser, A. H. V. Schapira, P. Barone, Y. Mizuno, O. Rascol, M. Busse, C. Debieuvre, M. Fraessdorf, W. Poewe and for the Pramipexole ER Studies Group

    Article first published online : 4 FEB 2014, DOI: 10.1111/ene.12375

  15. Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2542–2549, Robert A. Hauser, Anthony H.V. Schapira, Olivier Rascol, Paolo Barone, Yoshikuni Mizuno, Laurence Salin, Monika Haaksma, Nolwenn Juhel and Werner Poewe

    Article first published online : 10 NOV 2010, DOI: 10.1002/mds.23317

  16. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin

    European Journal of Neurology

    Volume 21, Issue 2, February 2014, Pages: 260–266, C. S. Lee, S. D. Lee, S.-H. Kang, H. Y. Park and I.-Y. Yoon

    Article first published online : 23 NOV 2013, DOI: 10.1111/ene.12286

  17. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  18. Pre-clinical studies of pramipexole: clinical relevance

    European Journal of Neurology

    Volume 7, Issue s1, May 2000, Pages: 15–20, J. P. Hubble

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1468-1331.2000.0070s1015.x

  19. Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study

    European Journal of Neurology

    Volume 10, Issue 4, July 2003, Pages: 399–406, I. Rektorová, I. Rektor, M. Bareš, V. Dostál, E. Ehler, Z. Fanfrdlová, J. Fiedler, H. Klajblová, P. Kulišt’ák, P. Ressner, J. Svátová, K. Urbánek and J. Velísková

    Article first published online : 19 JUN 2003, DOI: 10.1046/j.1468-1331.2003.00612.x

  20. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke, Julie Speller and J A Clarke

    Published Online : 24 APR 2000, DOI: 10.1002/14651858.CD002259